Biogen and Bio-Thera Announce Positive Results From Phase 3 Study of BAT1806, a Proposed Biosimilar Referencing Actemra® (Tocilizumab)

Suma Ramadas, PhD
Medical Affairs

Matthew Durham
Omnidynamic Marketing

Amy Giles
Increasing Engagement

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access